CONNECT WITH US
Tech

Tech

Ultraviolette Launches New E-Bike X-47 Venom With A ₹2.65 Lakh Price Tag

Inc42 - All News logo

Published on

Add as a preferred source on Google
Ultraviolette Launches New E-Bike X-47 Venom With A ₹2.65 Lakh Price Tag

A month after raising $85 Mn, e-bike maker Ultraviolette has unveiled its new motorcycle, X-47 Venom powered by its new VX-100 100V platform.

The motorcycle has been launched at an introductory price of ₹2.65 Lakh, applicable to the first 5,000 customers. Bookings opened on October 22. Deliveries are expected to commence in November 2026, the startup said in a press release.

The X-47 Venom is the first motorcycle built on Ultraviolette’s new VX-100 architecture. It combines the platform with its new UV LIGHTFURY electric motor and SRB-11 battery technology. It has peak power of 30 kW (39 bhp) and a 550 Nm of wheel torque. The Ultraviolette X-47 Venom is built to have a top speed of 155 kmph.

The motorcycle offers a claimed Indian Driving Cycle (IDC) range of 343 km. It can accelerate from 0 to 100 kmph in 5.9 seconds and has a kerb weight of 180 kg, making it up to 20 kg lighter than the previous-generation platform.

The VX-100 is a new electrical architecture designed to improve energy efficiency, thermal management and charging speeds across Ultraviolette’s product portfolio.

The platform incorporates SRB-11 battery technology, which the startup claims offers up to 20% higher energy density and twice the cooling performance. Its thermal management system is designed to dissipate heat up to 50% faster, while the battery pack features a cast-aluminium housing and IP67 protection against dust and water ingress.

The motorcycle also features a new motor control unit that is twice as compact and delivers three times the power density, according to the company.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.